Helminth infection can reduce insulitis and type 1 diabetes through CD25- and IL-10-independent mechanisms (scientific article published on 14 September 2009)

Chronic helminth infection induces alternatively activated macrophages expressing high levels of CCR5 with low interleukin-12 production and Th2-biasing ability.

Q34126175

Helminth parasites--masters of regulation

Q35884205

IL-2 and autocrine IL-4 drive the in vivo development of antigen-specific Th2 T cells elicited by nematode parasites

Q35995946

Infections and autoimmunity--good or bad?

Q36156243

Mucosal immunity and allergic responses: lack of regulation and/or lack of microbial stimulation?

Q36209726

Rising incidence of insulin dependent diabetes in children aged under 5 years in the Oxford region: time trend analysis. The Bart's-Oxford Study Group

Q36246394

Regulatory T cells induced by parasites and the modulation of allergic responses

Q36279713

Infections and autoimmune diseases

Q36309436

The role of macrophages in T cell-mediated autoimmune diabetes in nonobese diabetic mice

Q36367908

Suppression of allergic airway inflammation by helminth-induced regulatory T cells

Q36403704

Protective immune mechanisms in helminth infection

Q36481763

Disruption of the homeostatic balance between autoaggressive (CD4+CD40+) and regulatory (CD4+CD25+FoxP3+) T cells promotes diabetes

Q36803833

Alternatively activated macrophages in helminth infections

Q36911886

Checkpoints in the progression of autoimmune disease: lessons from diabetes models

Q37689425

Essential contribution of macrophages to islet cell destruction in vivo and in vitro

Q37852905

Heligmosomoides polygyrus: CD4+ but not CD8+ T cells regulate the IgE response and protective immunity in mice

Q39243584

Epidemiology of type I diabetes mellitus in Switzerland: steep rise in incidence in under 5 year old children in the past decade

Q39564743

Nippostrongylus brasiliensis can induce B7-independent antigen-specific development of IL-4-producing T cells from naive CD4 T cells in vivo

Q39637305

Protective effect of Schistosoma mansoni infection on allergic airway inflammation depends on the intensity and chronicity of infection

Q40184958

Influence of alternatively and classically activated macrophages on fibrogenic activities of human fibroblasts

Q40852538

The inhibitory function of B7 costimulators in T cell responses to foreign and self-antigens

Q42441813

Incidence of childhood type 1 diabetes worldwide. Diabetes Mondiale (DiaMond) Project Group

Q43607374

Increased nonobese diabetic Th1:Th2 (IFN-gamma:IL-4) ratio is CD4+ T cell intrinsic and independent of APC genetic background

Q44223925

Schistosoma mansoni antigens modulate the activity of the innate immune response and prevent onset of type 1 diabetes

Q44474619

Macrophage galactose-type C-type lectins as novel markers for alternatively activated macrophages elicited by parasitic infections and allergic airway inflammation.

Q45182747

Reciprocal immunomodulation in a schistosome and hepatotropic virus coinfection model

Q45422751

Mechanism underlying counterregulation of autoimmune diabetes by IL-4.

Q46801494

Alternative macrophage activation is essential for survival during schistosomiasis and downmodulates T helper 1 responses and immunopathology.

Q46899191

Immunomodulation of experimental autoimmune encephalomyelitis by helminth ova immunization.

Q48419105

The pathogenicity of islet-infiltrating lymphocytes in the non-obese diabetic (NOD) mouse.

Q50535751

Type 1 diabetes mellitus in Czech children diagnosed in 1990-1997: a significant increase in incidence and male predominance in the age group 0-4 years. Collaborators of the Czech Childhood Diabetes Registry.

Q50657133

Acute hepatitis C without and with schistosomiasis: correlation with hepatitis C-specific CD4(+) T-cell and cytokine response.

Q52934133

The countervailing actions of myeloid and plasmacytoid dendritic cells control autoimmune diabetes in the nonobese diabetic mouse.

Q53524050

CD4+CD25+ regulatory T cells control the progression from periinsulitis to destructive insulitis in murine autoimmune diabetes.

Q53846131

Infection with Schistosoma mansoni prevents insulin dependent diabetes mellitus in non-obese diabetic mice

Q58312813

Low dose chronic Schistosoma mansoni infection increases susceptibility to Mycobacterium bovis BCG infection in mice

Q58779406

Intestinal Helminths Protect in a Murine Model of Asthma

Q60147716

Recombinant human IL-10 prevents the onset of diabetes in the nonobese diabetic mouse

Q72415292

Aberrant macrophage cytokine production is a conserved feature among autoimmune-prone mouse strains: elevated interleukin (IL)-12 and an imbalance in tumor necrosis factor-alpha and IL-10 define a unique cytokine profile in macrophages from young no

Q74051997

Oral administration of schistosome egg antigens and insulin B-chain generates and enhances Th2-type responses in NOD mice

Q74518755

Dynamics of pathogenic and suppressor T cells in autoimmune diabetes development

Q79125427

Cyclophosphamide-induced type-1 diabetes in the NOD mouse is associated with a reduction of CD4+CD25+Foxp3+ regulatory T cells

Q79326703

Intestinal helminth co-infection has a negative impact on both anti-Mycobacterium tuberculosis immunity and clinical response to tuberculosis therapy

Q79440724

Murine gammaherpesvirus-68 infection alters self-antigen presentation and type 1 diabetes onset in NOD mice

Q79912641

Infection with a helminth parasite prevents experimental colitis via a macrophage-mediated mechanism

Q79984979

Distinct local immunogenic stimuli dictate differential requirements for CD4+ and CD8+ T cell subsets in the pathogenesis of spontaneous autoimmune diabetes

Q81510784

P433

issue

P407

language of work or name

English

Q1860

P921

main subject

type-1 diabetes

Q124407

insulitis

Q922215

P304

page(s)

5347-5358

P577

publication date

2009-09-14

P1433

published in

Infection and Immunity

Q6029193

P1476

title

Helminth infection can reduce insulitis and type 1 diabetes through CD25- and IL-10-independent mechanisms

P478

volume

Reverse relations

cites work (P2860)

Q26849454	Alternatively activated macrophages in types 1 and 2 diabetes
Q55019239	Atrophy of skin-draining lymph nodes predisposes for impaired immune responses to secondary infection in mice with chronic intestinal nematode infection.
Q35152520	Beyond genetics. Influence of dietary factors and gut microbiota on type 1 diabetes
Q93163082	CD8+ regulatory T cells are critical in prevention of autoimmune-mediated diabetes
Q49989611	Cell Type-Specific Immunomodulation Induced by Helminthes: Effect on Metainflammation, Insulin Resistance and Type-2 Diabetes.
Q36597276	Chronic Gastrointestinal Nematode Infection Mutes Immune Responses to Mycobacterial Infection Distal to the Gut.
Q30373454	Concise Review: Macrophages: Versatile Gatekeepers During Pancreatic β-Cell Development, Injury, and Regeneration.
Q39743937	Cultivation of Heligmosomoides polygyrus: an immunomodulatory nematode parasite and its secreted products
Q34341897	Decreased prevalence of lymphatic filariasis among subjects with type-1 diabetes
Q34833853	Differential changes in expression of intestinal antimicrobial peptide genes during Ascaris lumbricoides infection in Zambian adults do not respond to helminth eradication
Q26751236	Diplomatic Assistance: Can Helminth-Modulated Macrophages Act as Treatment for Inflammatory Disease?
Q47129733	Epithelial Barrier Function in Gut-Bone Signaling.
Q40509547	Foxp3(+) regulatory T cells in mouse models of type 1 diabetes
Q40216791	Globule Leukocytes and Other Mast Cells in the Mouse Intestine
Q33593313	Helminth Immunomodulation in Autoimmune Disease
Q37088203	Helminth infection and type 1 diabetes
Q26829956	Helminth infections and host immune regulation
Q34574142	Helminth infections decrease host susceptibility to immune-mediated diseases
Q37907365	Helminth infections: therapeutic potential in autoimmune disorders
Q35659179	Helminth protection against autoimmune diabetes in nonobese diabetic mice is independent of a type 2 immune shift and requires TGF-β.
Q34320469	Helminth secretome database (HSD): a collection of helminth excretory/secretory proteins predicted from expressed sequence tags (ESTs).
Q34030215	Helminth-host immunological interactions: prevention and control of immune-mediated diseases
Q28263272	Helminthic therapy: improving mucosal barrier function
Q38205868	Helminths in the hygiene hypothesis: sooner or later?
Q89485802	Human umbilical cord-derived mesenchymal stem cells direct macrophage polarization to alleviate pancreatic islets dysfunction in type 2 diabetic mice
Q37923560	Immune modulation and modulators in Heligmosomoides polygyrus infection.
Q34611614	Immune regulators of inflammation in obesity-associated type 2 diabetes and coronary artery disease
Q28276729	Immunity to the model intestinal helminth parasite Heligmosomoides polygyrus
Q35645163	Immunological Basis for Rapid Progression of Diabetes in Older NOD Mouse Recipients Post BM-HSC Transplantation
Q39012899	Immunomodulation by helminths: Similar impact on type 1 and type 2 diabetes?
Q41480089	Immunoregulation by Taenia crassiceps and its antigens
Q34229909	Improving power of genome-wide association studies with weighted false discovery rate control and prioritized subset analysis
Q38202992	Induction of regulatory cells by helminth parasites: exploitation for the treatment of inflammatory diseases
Q54273326	Macroparasites at peripheral sites of infection are major and dynamic modifiers of systemic antimicrobial pattern recognition responses.
Q38636165	Mast cells: new therapeutic target in helminth immune modulation
Q58578200	Metabolic consequences of concomitant Strongyloides stercoralis infection in Type 2 diabetes mellitus
Q36430262	Nematode-bacterium symbioses--cooperation and conflict revealed in the "omics" age.
Q35676595	Parasitic helminths and their beneficial impact on type 1 and type 2 diabetes.
Q37695081	Parasitic helminths: new weapons against immunological disorders
Q36911393	Parasitic nematode-induced modulation of body weight and associated metabolic dysfunction in mouse models of obesity
Q48027278	Prevention of Type 1 diabetes through parasite infection.
Q84582129	Prevention of type 1 diabetes through infection with an intestinal nematode parasite requires IL-10 in the absence of a Th2-type response
Q38024272	Prevention or acceleration of type 1 diabetes by viruses.
Q28477611	Proteomic analysis of excretory-secretory products of Heligmosomoides polygyrus assessed with next-generation sequencing transcriptomic information
Q36693917	Proteomic analysis of secretory products from the model gastrointestinal nematode Heligmosomoides polygyrus reveals dominance of venom allergen-like (VAL) proteins
Q46284091	Redox-Sensitive Innate Immune Pathways During Macrophage Activation in Type 1 Diabetes
Q40528318	Regulation of type 2 diabetes by helminth-induced Th2 immune response
Q37509600	Role of macrophages in the altered epithelial function during a type 2 immune response induced by enteric nematode infection
Q40115518	Schistosome egg antigens, including the glycoprotein IPSE/alpha-1, trigger the development of regulatory B cells.
Q34400239	Secreted proteins from the helminth Fasciola hepatica inhibit the initiation of autoreactive T cell responses and prevent diabetes in the NOD mouse
Q42571108	Suppression of type 2 immunity and allergic airway inflammation by secreted products of the helminth Heligmosomoides polygyrus.
Q35148851	Systemic impact of intestinal helminth infections
Q47153984	Taenia crassiceps Antigens Control Experimental Type 1 Diabetes by Inducing Alternatively Activated Macrophages
Q47611584	The hygiene hypothesis in autoimmunity: the role of pathogens and commensals
Q37031687	The hygiene hypothesis: current perspectives and future therapies
Q41384451	The potential long-term effect of previous schistosome infection reduces the risk of metabolic syndrome among Chinese men.
Q39406411	Therapeutic potential of helminths in autoimmune diseases: helminth-derived immune-regulators and immune balance
Q38872412	Therapeutic potential of the immunomodulatory proteins Wuchereria bancrofti L2 and Brugia malayi abundant larval transcript 2 against streptozotocin-induced type 1 diabetes in mice.
Q38125248	Trichinella spiralis immunomodulation: an interactive multifactorial process
Q90564184	Tuftsin phosphorylcholine-a novel compound harnessing helminths to fight autoimmunity
Q27004109	Understanding the role of antibodies in murine infections with Heligmosomoides (polygyrus) bakeri: 35 years ago, now and 35 years ahead
Q28082281	Unraveling the Hygiene Hypothesis of helminthes and autoimmunity: origins, pathophysiology, and clinical applications

P356	DOI	10.1128/IAI.01170-08
P8608	Fatcat ID	release_wbn2jalmbff2bl5sw6rc4pnvdq
P932	PMC publication ID	2786463
P698	PubMed publication ID	19752032
P5875	ResearchGate publication ID	26810052